Search

Found 361 Results
Page 1 of 37

Direct Dirigeants


DIRECT DIRIGEANTS – EasyBourse A debate during which Onxeo’s CEO presents the company’s development strategy, activities, results and prospects.   […]

12/03/2020




Onxeo Has Applied for Admission to Trading on Nasdaq First North Growth Market Denmark and Delisting from Nasdaq Main Market Copenhagen


Paris (France), November 27, 2020 – 6 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

11/27/2020


Analysts call following DRIIV-1b interim results


November 9, 2020 Access management presentation Access live webcast replay

11/12/2020


Onxeo Announces Completion of Patient Enrollment in DRIIV-1b Study and Positive Interim Results


The last patient was treated with AsiDNA™ in combination with carboplatin and paclitaxel in this Phase 1b study in patients […]

Tags:

11/09/2020


AACR Annual Meeting 2021


  Discovery Science Driving Clinical Breakthroughs For more information…  

10/28/2020


4th Annual PARP & DDR Inhibitors Summit


  For more information and to register…


H.C. Wainwright BioConnect 2021 Conference


More information coming soon …


Bryan Garnier & Co European Healthcare Conference


The annual European Healthcare Conference is one of the top events organized by Bryan, Garnier & Co. By invitation only, […]


Page 1 of 37

No more results